Genetic Treatment for Blindness May Soon be Reality

Sunday, November 12, 2017 - 16:51

Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy.

According to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology, patients in the study had a condition called Leber congenital amaurosis (LCA), which begins in infancy and progresses slowly, eventually causing complete blindness. This new, first-of-its-kind gene therapy is currently under review by the U.S. Food and Drug Administration for potential approval this year. There are currently no treatments available for inherited retinal diseases.

Ophthalmologist Stephen R. Russell, M.D., of the University of Iowa, is one of the lead researchers for this pioneering treatment. Data from the first randomized, controlled, phase 3 study showed that 27 of 29 treated patients (93 percent) experienced meaningful improvements in their vision, enough that they could navigate a maze in low to moderate light. They also showed improvement in light sensitivity and peripheral vision, which are two visual deficits these patients experience, Science Daily reports.

Approval could open the door for other gene therapies that could eventually treat the more than 225 genetic mutations known to cause blindness. It could be applied to retinitis pigmentosa, another inherited retinal disease caused by a defective gene. Or in the future, gene therapy could possibly provide key proteins needed to restore vision in more common diseases such as age-related macular degeneration.

Treatment doesn't restore normal vision. It does, however, allow patients to see shapes and light, allowing them to get around without a cane or a guide dog. It is unclear how long the treatment will last, but so far, most patients have maintained their vision for two years.

However, no gene therapy has gotten this close to FDA approval for retinal disease or any other eye disease. In October, an advisory committee to the FDA unanimously endorsed the treatment. The FDA isn't obligated to follow the recommendations of its advisory committees, but it usually does. The agency is expected to make its decision no later than January 2018.

Related News

Some Blind People Can Still See, Researcher Explains

1399/4/15 10:48

Scientists Discover New Protein Linked to AMD

1398/11/19 10:10

Researchers Stimulate Optic Nerve to Aid the Blind

1398/6/3 16:40

S & R IAU Researchers Develop Targeted Drug Delivery Based on Magnetic Nanoparticles

1397/7/1 11:57

Researchers Develop Sugar Pills Flowing Through the Body Delivering Drug Treatments Where Needed

1397/6/17 13:24

Scientists Reverse Aging-Associated Skin Wrinkles & Hair Loss Through Gene Editing

1397/6/14 11:33

A Robot Operates a Human Eye For the First Time

1397/3/30 10:19

Experimental Gene Therapy Could Stitch Together Damaged Spinal Cords

1397/3/29 10:36

S & R IAU Researcher Develops a Method to Treat Abnormalities Associated with Retinal Diseases

1397/3/23 14:41

People Adapted to the Cold, Got More Migraines, Study Shows

1397/2/16 12:40

Ayatollah Amoli IAU Faculty Member Develops Approach For Industrial Wastewater Treatment

1396/12/21 15:03

Japanese Drugmaker Claims Experimental Drug Kills Flu Virus in a Single Day

1396/11/28 12:28

Iranian Researchers Discover New Effective Genes for Genetics of Intellectual Disability

1396/11/25 12:09

Iranian Researcher Discovers Hepatic Regulation Modulates Non-Alcoholic Fatty Liver Disease

1396/11/2 12:49

Tehran IAU Medical Branch Could Isolate the Pigments from the Psychrotrophic Bacteria

1396/10/11 10:30

Sanandaj IAU Researcher Develops a Smart Device for the Blind

1396/10/9 10:17

RIFST Researchers Create Non Thermal Pasteurization Device

1396/9/25 14:15

Researchers Reveal Microbot to Assist in Eye Operations

1395/9/18 17:11

"Hide and Seek" Depicts Human Loneliness in Technology

1394/8/25 23:24


Popular News

Latest News